SB-742457

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for SB-742457, covering 2008-12-25 to 2018-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease [Phase 2]